• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶抑制剂 MS-275 通过增强 Dhx36 介导的 TNAP 转录,部分刺激骨形成。

Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription.

机构信息

Department of Cell and Developmental Biology, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of Korea.

出版信息

J Bone Miner Res. 2011 Sep;26(9):2161-73. doi: 10.1002/jbmr.426.

DOI:10.1002/jbmr.426
PMID:21590736
Abstract

Histone deacetylases (HDACs) deacetylate both histones and nonhistone proteins and play a key role in the regulation of physiologic and aberrant gene expression. Inhibition of HDACs has emerged as a promising therapeutic target for cancer and neurologic diseases. In this study we investigated the osteogenic effect and mechanism of action of MS-275, a class I HDAC inhibitor with preference for HDAC1. Both local and systemic administration of MS-275 stimulated bone regeneration in animal models. MS-275 stimulated mRNA expression and activity of the early osteogenic marker tissue-nonspecific alkaline phosphatase (TNAP) in bone tissue and osteogenic cells. By using a series of TNAP promoter deletion constructs and a DNA affinity precipitation assay, we identified DExH-box helicase Dhx36 as a factor that binds to the MS-275 response element in the TNAP promoter. We also found that Dhx36 binding to the MS-275 response element is crucial for MS-275 induction of TNAP transcription. Dhx36 physically interacted with a subset of HDACs (HDAC1 and -4) whose protein levels were downregulated by MS-275, and forced expression of these HDACs blunted the stimulatory effects of MS-275 by a deacetylase activity-independent mechanism(s). Taken together, the results of our study show that MS-275 induces TNAP transcription by decreasing the interaction of HDAC1/4 with Dhx36, which can at least in part contribute to the bone anabolic effects of MS-275.

摘要

组蛋白脱乙酰基酶(HDACs)可使组蛋白和非组蛋白蛋白质脱乙酰化,并在调节生理和异常基因表达中发挥关键作用。抑制 HDACs 已成为癌症和神经疾病有前途的治疗靶标。在这项研究中,我们研究了 MS-275 的成骨作用和作用机制,MS-275 是一种具有 HDAC1 偏好性的 I 类 HDAC 抑制剂。MS-275 的局部和全身给药均可刺激动物模型中的骨再生。MS-275 刺激骨组织和成骨细胞中早期成骨标志物组织非特异性碱性磷酸酶(TNAP)的 mRNA 表达和活性。通过使用一系列 TNAP 启动子缺失构建体和 DNA 亲和沉淀测定,我们确定 DExH 框解旋酶 Dhx36 是与 TNAP 启动子中的 MS-275 反应元件结合的因子。我们还发现 Dhx36 与 MS-275 反应元件的结合对于 MS-275 诱导 TNAP 转录至关重要。Dhx36 与一组 HDACs(HDAC1 和 -4)物理相互作用,MS-275 下调这些 HDACs 的蛋白水平,并且强制表达这些 HDACs 通过去乙酰化酶活性非依赖性机制(s)削弱 MS-275 的刺激作用。总之,我们的研究结果表明,MS-275 通过减少 HDAC1/4 与 Dhx36 的相互作用来诱导 TNAP 转录,这至少部分有助于 MS-275 的骨合成作用。

相似文献

1
Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription.组蛋白去乙酰化酶抑制剂 MS-275 通过增强 Dhx36 介导的 TNAP 转录,部分刺激骨形成。
J Bone Miner Res. 2011 Sep;26(9):2161-73. doi: 10.1002/jbmr.426.
2
MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.MS-275,一种苯甲酰胺类组蛋白去乙酰化酶抑制剂,通过下调 c-Fos 表达来防止破骨细胞生成,并抑制小鼠的骨质流失。
Eur J Pharmacol. 2012 Sep 15;691(1-3):69-76. doi: 10.1016/j.ejphar.2012.07.034. Epub 2012 Jul 27.
3
Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.类别选择性组蛋白去乙酰化酶抑制剂对皮质神经元中脑源性神经营养因子(Bdnf)表达的差异性调控
Neuropharmacology. 2013 Dec;75:106-15. doi: 10.1016/j.neuropharm.2013.07.015. Epub 2013 Aug 2.
4
The Selective Histone Deacetylase Inhibitor MI192 Enhances the Osteogenic Differentiation Efficacy of Human Dental Pulp Stromal Cells.选择性组蛋白去乙酰化酶抑制剂MI192增强人牙髓基质细胞的成骨分化效能。
Int J Mol Sci. 2021 May 14;22(10):5224. doi: 10.3390/ijms22105224.
5
The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.肠上皮细胞分化标志物肠碱性磷酸酶(ALPi)在结肠癌细胞中可被组蛋白去乙酰化酶抑制剂(HDACi)以依赖 Kruppel 样因子 5(KLF5)的方式选择性诱导。
J Biol Chem. 2014 Sep 5;289(36):25306-16. doi: 10.1074/jbc.M114.557546. Epub 2014 Jul 18.
6
Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1.组蛋白去乙酰化酶抑制剂调节鸟苷酸环化酶/利钠肽受体-a 基因的转录调控:修饰组蛋白、组蛋白乙酰转移酶、p300 和 Sp1 的相互作用。
J Biol Chem. 2014 Mar 7;289(10):6991-7002. doi: 10.1074/jbc.M113.511444. Epub 2014 Jan 22.
7
Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.曲古抑菌素 A 通过抑制组蛋白去乙酰化酶 2 和 3 诱导 5-脂氧合酶启动子活性和 mRNA 表达。
J Cell Mol Med. 2012 Jul;16(7):1461-73. doi: 10.1111/j.1582-4934.2011.01420.x.
8
Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro.I 类和 II 类组蛋白去乙酰化酶抑制剂可抑制体外人破骨细胞。
J Cell Physiol. 2011 Dec;226(12):3233-41. doi: 10.1002/jcp.22684.
9
Histone deacetylase inhibitors promote osteoblast maturation.组蛋白去乙酰化酶抑制剂可促进成骨细胞成熟。
J Bone Miner Res. 2005 Dec;20(12):2254-63. doi: 10.1359/JBMR.050813. Epub 2005 Aug 8.
10
Histone deacetylase inhibition by MS-275 potentiates glucose-stimulated insulin secretion without affecting glucose oxidation.组蛋白去乙酰化酶抑制药 MS-275 增强葡萄糖刺激的胰岛素分泌而不影响葡萄糖氧化。
Life Sci. 2020 Sep 15;257:118073. doi: 10.1016/j.lfs.2020.118073. Epub 2020 Jul 11.

引用本文的文献

1
Unlocking the Epigenetic Symphony: Histone Acetylation Orchestration in Bone Remodeling and Diseases.解开表观遗传交响曲:骨重塑与疾病中的组蛋白乙酰化调控
Stem Cell Rev Rep. 2025 Feb;21(2):291-303. doi: 10.1007/s12015-024-10807-2. Epub 2024 Nov 4.
2
The histone deacetylase inhibitor MS-275 enhances the matrix mineralization of dental pulp stem cells by inducing fibronectin expression.组蛋白去乙酰化酶抑制剂MS-275通过诱导纤连蛋白表达增强牙髓干细胞的基质矿化。
J Dent Sci. 2024 Jul;19(3):1680-1690. doi: 10.1016/j.jds.2023.11.019. Epub 2023 Dec 3.
3
Endocrine, auxological and metabolic profile in children and adolescents with Down syndrome: from infancy to the first steps into adult life.
唐氏综合征儿童和青少年的内分泌、生长学及代谢特征:从婴儿期到步入成年生活的最初阶段
Front Endocrinol (Lausanne). 2024 Apr 8;15:1348397. doi: 10.3389/fendo.2024.1348397. eCollection 2024.
4
Exploring epigenetic strategies for the treatment of osteoporosis.探索用于治疗骨质疏松症的表观遗传策略。
Mol Biol Rep. 2024 Mar 8;51(1):398. doi: 10.1007/s11033-024-09353-4.
5
Cyclophilin E (CypE) Functions as a Positive Regulator in Osteoblast Differentiation by Regulating the Transcriptional Activity of Runx2.亲环素 E(CypE)通过调节 Runx2 的转录活性在成骨细胞分化中作为正调节剂发挥作用。
Cells. 2023 Oct 31;12(21):2549. doi: 10.3390/cells12212549.
6
Role of histone modification in the occurrence and development of osteoporosis.组蛋白修饰在骨质疏松症发生发展中的作用。
Front Endocrinol (Lausanne). 2022 Aug 26;13:964103. doi: 10.3389/fendo.2022.964103. eCollection 2022.
7
To unwind the biological knots: The DNA/RNA G-quadruplex resolvase RHAU (DHX36) in development and disease.解开生物结:在发育和疾病中的 DNA/RNA G-四链体解旋酶 RHAU(DHX36)。
Animal Model Exp Med. 2022 Dec;5(6):542-549. doi: 10.1002/ame2.12251. Epub 2022 Jul 4.
8
Epigenetic therapy targeting bone marrow mesenchymal stem cells for age-related bone diseases.针对与年龄相关的骨骼疾病的骨髓间充质干细胞的表观遗传治疗。
Stem Cell Res Ther. 2022 May 16;13(1):201. doi: 10.1186/s13287-022-02852-w.
9
Epigenetic regulation of dental pulp stem cells and its potential in regenerative endodontics.牙髓干细胞的表观遗传调控及其在牙髓再生中的潜力。
World J Stem Cells. 2021 Nov 26;13(11):1647-1666. doi: 10.4252/wjsc.v13.i11.1647.
10
Action and function of helicases on RNA G-quadruplexes.解旋酶在 RNA G-四链体上的作用和功能。
Methods. 2022 Aug;204:110-125. doi: 10.1016/j.ymeth.2021.09.003. Epub 2021 Sep 10.